Ribozymes as therapies for AIDS
- PMID: 2078019
- DOI: 10.1111/j.1749-6632.1990.tb17839.x
Ribozymes as therapies for AIDS
Similar articles
-
Ribozymes as potential anti-HIV-1 therapeutic agents.Science. 1990 Mar 9;247(4947):1222-5. doi: 10.1126/science.2107573. Science. 1990. PMID: 2107573
-
A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.Nucleic Acids Res. 1994 Nov 25;22(23):5060-7. doi: 10.1093/nar/22.23.5060. Nucleic Acids Res. 1994. PMID: 7800500 Free PMC article.
-
Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.Antisense Res Dev. 1991 Fall;1(3):285-8. Antisense Res Dev. 1991. PMID: 1821650 Review.
-
RNA enzymes (ribozymes) as antiviral therapeutic agents.Trends Biotechnol. 1990 Jul;8(7):179-83. doi: 10.1016/0167-7799(90)90169-x. Trends Biotechnol. 1990. PMID: 1366622 Review.
-
In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.RNA Biol. 2011 Mar-Apr;8(2):343-53. doi: 10.4161/rna.8.2.15200. Epub 2011 Mar 1. RNA Biol. 2011. PMID: 21422817
Cited by
-
Construction of a novel RNA-transcript-trimming plasmid which can be used both in vitro in place of run-off and (G)-free transcriptions and in vivo as multi-sequences transcription vectors.Nucleic Acids Res. 1991 Oct 11;19(19):5125-30. doi: 10.1093/nar/19.19.5125. Nucleic Acids Res. 1991. PMID: 1923797 Free PMC article.
-
Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.J Investig Med. 2014 Oct;62(7):914-9. doi: 10.1097/JIM.0000000000000103. J Investig Med. 2014. PMID: 25118114 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical